7 completed, 5 unknown, 2 recruiting, 1 active not recruiting. 5 Phase 3, 4 Phase 4, 3 Not applicable, 2 Phase 1, 1 Phase 2.
Follow Combined oral contraceptive: new trials by email Literature Review of Combined oral contraceptive trials Research Report on Combined oral contraceptive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight Eloralintide, Combined oral contraceptive - Obesity, Overweight | Phase 1 | Recruiting | Eli Lilly and Company | 34 | 2026-09-15 | 2026-10-08 |
| Impact of Combined Oral Contraceptive Pills on Migraine Combined oral contraceptive, Vaginal Ring - Migraine | Phase 4 | Recruiting | Kafrelsheikh University | 400 | 2024-07-15 | 2024-10-09 |
| Evaluation of the Effects of Diosmin/Hespiridin Combination on the Clinical Outcomes in Patients With Polycystic Ovary Syndrome Daflon, Combined oral contraceptive, Metformin - Poly Cystic Ovary Syndrome | Phase 4 | Unknown | Ain Shams University | 120 | 2023-11-01 | 2023-10-16 |
| Comparing the Safety and Efficacy in the Use of Hormonal Therapy on Endometriosis Patients After Conservative Surgery Dienogest, Depo Medroxyprogesterone acetate, Leuprolide (as Leuprolide Acetate) - Endometriosis Ovary | Phase 3 | Completed | Universitas Diponegoro | 80 | 2023-09-04 | 2024-12-11 |
| Treat of Functional Ovarian Cysts by Compare Between Cocs and Progesterone Only Pills Combined Oral Contraceptive, Progestin - Ovarian Neoplasms | Phase 3 | Unknown | Sohag University | 60 | 2022-02-20 | 2022-02-17 |
| The Pill Project - Oral Contraceptive and Serotonergic Brain Signaling Femicept, Placebo - Major Depressive Disorder, Sexual Behavior | Not applicable | Unknown | Copenhagen University Hospital, Rigshospitalet | 40 | 2021-12-22 | 2022-02-28 |
| Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders Duphaston, Gonadotropin, Cetrotide Injectable Product - Infertility, Female | Phase 3 | Completed | El Shatby University Hospital for Obstetrics and Gynecology | 90 | 2020-09-01 | 2022-02-17 |
| Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain Elagolix, Placebo, Combined Oral Contraceptive - Endometriosis | Phase 3 | Active not recruiting | AbbVie | 800 | 2020-08-10 | 2026-06-12 |
| The Influence of Combined Oral Contraception on the DEvelopment and progRession of Chronic venoUs diSeases Combined Oral Contraceptive - Chronic Venous Diseases | Not applicable | Completed | Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia | 116 | 2020-06-24 | 2026-03-05 |
| Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis Dienogest, Combined Oral Contraceptive - Adenomyosis | Phase 4 | Unknown | Assiut University | 100 | 2018-11-01 | 2018-08-31 |
| Oral AQX-1125 and Combination Oral Contraceptive Drug-Drug Interaction Study AQX-1125, Combined Oral Contraceptive - Healthy Volunteer | Phase 1 | Completed | Aquinox Pharmaceuticals (Canada) Inc. | 32 | 2017-11-22 | 2018-06-13 |
| Efficacy of Dienogest Versus Oral Contraceptive Pills on Pain Associated With Endometriosis Dienogest 2 MG Oral Tablet, Yasmin - Endometriosis | Phase 2 / Phase 3 | Unknown | American University of Beirut Medical Center | 100 | 2017-02-07 | 2021-04-15 |
| Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis Combined Oral Contraceptive, Transdermal Contraceptive, Contraceptive Vaginal Ring - Bone; Disorder, Development and Growth | Phase 4 | Completed | Penn State University | 60 | 2015-01-01 | 2020-03-09 |
| HSG and Tubal Patency Study combined oral contraceptive, DepoProvera - Tubal Patency | Not applicable | Completed | Jeffrey Jensen | 11 | 2014-05-01 | 2017-03-22 |
| Metabolic Profile of Users of Hormonal and Non-hormonal Contraceptives Intrauterine device, Combined Oral Contraceptive, Progestin-only pills - Contraceptive Usage, Metabolic Syndrome | Completed | Federal University of São Paulo | 489 | 2010-01-01 | 2017-12-26 |
Endometriosis (2) · Obesity (2) · Adenomyosis (1) · Body Weight Changes (1) · Contraception Behavior (1) · Depressive Disorder, Major (1) · Dysmenorrhea (1) · Infertility, Female (1) · Metabolic Syndrome (1) · Migraine Disorders (1) · Ovarian Neoplasms (1) · Overweight (1) · Sexual Behavior (1)
AbbVie (1) · Ain Shams University (1) · American University of Beirut Medical Center (1) · Aquinox Pharmaceuticals (Canada) Inc. (1) · Assiut University (1) · Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia (1) · Copenhagen University Hospital, Rigshospitalet (1) · El Shatby University Hospital for Obstetrics and Gynecology (1) · Eli Lilly and Company (1) · Federal University of São Paulo (1) · Jeffrey Jensen (1) · Kafrelsheikh University (1) · Penn State University (1) · Sohag University (1) · Universitas Diponegoro (1)
United States (4) · Egypt (2) · Brazil (1) · Denmark (1) · Indonesia (1) · Lebanon (1) · Netherlands (1) · Puerto Rico (1) · Russia (1)
Alexey Fokin (1) · Aly A Hussein, Ass.lecturer (1) · Antoine Abu Musa, MD (1) · Jeffrey Jensen, MD MPH (1) · Jeroen van de Wetering, MD (1) · Mary Jane De Souza, PhD (1) · Sherif S Gaafar, Professor (1) · Vibe Frokjaer, MD, PhD (1) · Yuli Trisetiyono, SpOG (K) (1)
PMID 11914403, PMID 12807523, PMID 32612574, PMID 34826668, PMID 8984084